阿奇霉素治疗小儿肺炎支原体感染合并咳嗽变异性哮喘的临床疗效观察

打开文本图片集

【摘 要】目的：在进行肺炎支原体感染合并咳嗽性哮喘小儿疾病治疗时，应用阿奇霉素治疗疗效。方法：选择2019年1月至2020年1月本院诊治的80例肺炎支原体感染患者，全部患者合并咳嗽性哮喘。分别纳入康复组（总共40例）与对比组（总共40例）。康复组和对比组各自应用阿奇霉素与红霉素肠溶胶囊医治。结果：医治后，康复组的医治成功率为95.0%，复发性为7.5%，对比组的医治成功率为77.5%，复发性为25.0%，差别存有明显的统计学意义（P

【关键词】红霉素肠溶胶囊；阿奇霉素；肺炎支原体；肺炎；咳嗽性哮喘

Clinical observation of azithromycin in the treatment of Mycoplasma pneumoniae infection complicated with cough variant asthma in children

HOU Baoyu

Department of Pediatrics， Dongming people’s Hospital， Heze Shandong 274500， China

【Abstract】Objective： To study the efficacy of using azithromycin in the diagnosis and treatment of children with Mycoplasma pneumoniae infection combined with cough variant asthma. Methods： Selecting 80 patients with Mycoplasma pneumoniae infection diagnosed and treated in our hospital from January 2019 to January 2020， all patients were complicated with cough variant asthma. They were included in the rehabilitation group （40 cases in total） and the control group（40 cases in total）.The rehabilitation group and the control group were treated with azithromycin and erythromycin enteric-coated capsules respectively. Results： After treatment， the treatment success rate of the rehabilitation group was 95.0%， and the recurrence rate was 7.5% in the rehabilitation group， and the treatment success rate of the control group was 77.5%， and the recurrence rate was 25.0% in the control group. The differences were statistically significant（P

【Key？Words】Erythromycin enteric-coated capsules； Azithromycin；Mycoplasma pneumonia； Pneumonia； Cough variant asthma

在临床医学上，支气管哮喘属于呼吸类的疾病，患病率非常高，这种病症往往存在独特的类型便是变异性哮喘，发病原因往往是由于肺部的支原体感染造成[1]。（剩余3042字）